New FDA application for wound-care product submitted by Cardium

08/30/2013 | (Boston)

Cardium Therapeutics has filed a new 510(k) clearance application with the FDA for its wound-therapy product called Excellagen. The new submission includes packaging modifications, more specific labeling and research data indicating that the product can boost platelet activation when used in conjunction with platelet-rich plasma therapy.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID